UNSPSC 51142405: Combination acetaminophen acetylsalicylic acid

This classification denotes a combination drug that treats migraines. The first component of this drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but generally known as acetaminophen (or paracetamol), which bears US NIH Compound Identifier 1983.

Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate. European Medicines Agency schedules Acetaminophen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09611MIG. World Health Organization schedules acetaminophen in its Anatomical Therapeutic Chemical (ATC) Classification. SMILES: OC1CCC(NC(=O)C)CC1.

UNSPSC 51142405 Combination acetaminophen acetylsalicylic acid is a Commodity code that, based on recent state and local procurement activity, describes pharmaceuticals and over-the-counter (OTC) products supplied through authorized wholesaler networks and direct-to-government channels rather than the specific drug combination its name suggests. State and local buyers under this code range from county health departments to multistate cooperative purchasing alliances and state health and human services commissions. Recent solicitations show procurement bodies acquiring generic pharmaceuticals, naloxone, drug deactivation systems, and OTC products for community health initiatives, pharmacy benefit programs, and distributed government facility networks. The issuing bodies include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), and cooperative purchasing organizations operating across multiple jurisdictions (Minnesota Multistate Cooperative Purchasing Alliance).

Geographic activity concentrates in Florida, Texas, and Minnesota, with multistate cooperative purchasing extending participation to additional states including Oregon. Representative recent opportunities include Seminole County's IFB60459723LAS, an IFB posted June 30, 2026, with response due July 26, 2023, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a two-year term with one-year renewal option; the Texas Health and Human Services Commission's RFI HHS0017013, posted April 3, 2026, gathering market intelligence on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager arrangements; and the Minnesota Department of Administration's MMCAP RFP S1070000015802, posted January 20, 2026, with proposals due March 26, 2026, establishing multistate contracts for generic pharmaceuticals and OTC products through three authorized wholesalers (Cencora, Cardinal Health, and Morris & Dickson) with awards effective July 1, 2026. Vendors must meet FDA compliance, cGMP certification, DSCSA requirements, and maintain insurance coverage including commercial general liability of $5 million per occurrence.